Skip to main content

Table 1 Characteristics of the CAD population (n = 1001).

From: Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study

Age (years, mean (range)) 62 (36-81)
Men/Women n (%) 783/218 (78/22)
Type 2 Diabetes Mellitus n (%) 200 (20)
Myocardial infarction n (%) 436 (44)
Hypertension n (%) 553 (56)
Metabolic syndrome n (%) 244 (24)
SBP (mmHg) 139.4 (19.3)
DBP (mmHg) 82.1 (9.7)
Current smokers n (%) 204 (20.4)
BMI (kg/m2) 27.9 (11.5)
Total cholesterol (mmol/L) 4.6 (1.0)
HDL cholesterol (mmol/L) 1.3 (0.4)
LDL cholesterol (mmol/L) 2.5 (0.8)
Triglycerides (mmol/L) 1.6 (1.1)
Fasting glucose (mmol/L) 6.0 (1.9)
IL-18 pg/mL 248.0 (195.3, 322.7)*
IL-18 BP pg/mL 23.2 (19.2, 28.2)*
HbA1c (%) 6.0 (0.9)
Medication %  
   Statins 98
   Aspirin 100
   β-Blockers 76
   Nitrates 22
   ACE inhibitors 26
  1. Values are mean (SD) or number (proportions) if not otherwise stated
  2. SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; ACE: angiotensin converting enzyme.
  3. * Median levels (25- and 75 percentiles)